Profil
Daniel Emerling is the founder of Atreca, Inc. which is founded in 2010, where he holds the title of Senior Vice President-Research.
He held the position of Senior Director-Preclinical Pharmacology at Renovis, Inc. from 2000 to 2009 and Senior Director-Pharmacology at Nuon Therapeutics, Inc. from 2010 to 2011.
Dr. Emerling holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Daniel Emerling
| Sociétés | Poste | Début |
|---|---|---|
| ATRECA, INC. | Founder | 11/06/2010 |
Anciens postes connus de Daniel Emerling
| Sociétés | Poste | Fin |
|---|---|---|
Nuon Therapeutics, Inc.
 Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/01/2011 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Corporate Officer/Principal | 01/01/2009 |
Formation de Daniel Emerling
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATRECA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Health Technology |
